COMMUNIQUÉS West-GlobeNewswire
-
EssilorLuxottica: Déclaration de transactions sur actions propres
10/09/2024 - 18:00 -
Communiqué de presse : Sanofi inaugure la première usine modulable de vaccins et biomédicaments au monde à Neuville-sur-Saône
10/09/2024 - 17:00 -
Baylor Genetics Named to Fast Company’s Best Workplaces for Innovators List
10/09/2024 - 16:45 -
ADIA Nutrition Appoints Dr. Richard Edwards, DO as Second Medical Director
10/09/2024 - 16:00 -
Culture Biosciences and Google Cloud Announce Collaboration to Revolutionize Bioprocess Development
10/09/2024 - 16:00 -
Wake Radiology Adds Eight Physicians to Serve Patients in Multiple Specialty Areas
10/09/2024 - 16:00 -
Roche opens Pharma Research and Development Center in Basel to accelerate scientific innovation
10/09/2024 - 16:00 -
Smith+Nephew brings pre-operative planning and accuracy to total ankle replacement with new TOTAL ANKLE Patient-Matched Guides
10/09/2024 - 16:00 -
VitalHub Corp. Recognized Among Top Performers in the 2024 TSX30 Ranking
10/09/2024 - 15:50 -
U.S. Oral Surgery Management Enters New Hampshire
10/09/2024 - 15:35 -
Virbac : Declaration of the number of shares and voting rights 08/2024
10/09/2024 - 15:24 -
Virbac : Déclaration d'actions et de droits de vote 08/2024
10/09/2024 - 15:24 -
Virbac : Declaration of the number of shares and voting rights 07/2024
10/09/2024 - 15:17 -
Virbac : Déclaration d'actions et de droits de vote 07/2024
10/09/2024 - 15:17 -
Methodist Healthcare Adopts IR-MED’s PressureSafe™ Device for Usability Study: Decision Support Device Aims to Reduce Substantial Healthcare Burden of Pressure Injuries
10/09/2024 - 15:15 -
WeightWatchers Announces Strategic Leadership Team Appointments
10/09/2024 - 15:06 -
Tersa Earth Partners with Wet’suwet’en First Nation to Advance Sustainable Economic Growth
10/09/2024 - 15:03 -
ARS Pharmaceuticals Submits sNDA to FDA for neffy® 1 mg Dose for Pediatric Patients with Type I Allergic Reactions Who Weigh 15 to 30 kg (33-66 lbs.)
09/09/2024 - 22:47 -
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/09/2024 - 22:45
Pages